Correction of neurovascular deficits in diabetic rats by β2-adrenoceptor agonist and α1-adrenoceptor antagonist treatment: Interactions with the nitric oxide system

European Journal of Pharmacology

Volumn 343, Issue 2-3, 1998, Pages 217-223

  Cotter, Mary A ^a   Cameron, Norman E ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

1 Adrenoceptor; 2 Adrenoceptor; Blood flow; Diabetic rat; Nerve conduction; Neuropathy; Nitric oxide (NO)

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DOXAZOSIN; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SALBUTAMOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BLOOD VESSEL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG ANTAGONISM; ENDONEURIUM; MALE; MOTOR NERVE CONDUCTION; NERVE CONDUCTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DOXAZOSIN; ENZYME INHIBITORS; MALE; NEURAL CONDUCTION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA-2; STREPTOZOCIN;

EID: 0032545985     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01533-1     Document Type: Article

References (45)

1. Appenzeller O., Dhital K.K., Cowen T., Burnstock G. The nerves to blood vessels supplying blood to nerves: The innervation of vasa nervorum. Brain Res. 304:1984;383-386.
2. Archibald V., Cotter M.A., Keegan A., Cameron N.E. Contraction and relaxation of aortas from diabetic rats: Effects of chronic anti-oxidant and aminoguanidine treatments. Naunyn-Schmeidebergs Arch. Pharmacol. 353:1996;584-591.
3. Belfrage E. Comparison of beta-adrenoceptors mediating vasodilatation in canine subcutaneous adipose tissue and skeletal muscle. Acta Physiol. Scand. 102:1978;469-476.
4. Bravenboer B., Kapelle A.C., Hamers F.P.T., van Buren T., Erkelens D.W., Gispen W.H. Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia. 35:1992;813-817.
5. Cameron N.E., Cotter M.A. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: Role of polyol pathway activity. Diabetologia. 35:1992;1011-1019.
6. Cameron N.E., Cotter M.A. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab. Rev. 10:1994;189-224.
7. Cameron N.E., Cotter M.A. Reversal of peripheral nerve conduction and perfusion deficits by the free radical scavenger, BM15.0639, in diabetic rats. Naunyn-Schmeidebergs Arch. Pharmacol. 352:1995;685-690.
8. Cameron N.E., Cotter M.A. Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: Modulation by nitric oxide synthase inhibition. Metabolism. 45:1996;1147-1152.
9. A antagonist on neurovascular function in diabetic rats: Interaction with the renin-angiotensin system. J. Pharmacol. Exp. Ther. 278:1996;1262-1268.
10. Cameron N.E., Cotter M.A. Neurovascular effects of L-carnitine treatment in diabetic rats. Eur. J. Pharmacol. 319:1997;239-244.
11. Cameron N.E., Cotter M.A., Robertson S. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Q. J. Exp. Physiol. 74:1989;917-926.
12. +-ATPase activity and vascular supply in STZ-D rats. Diabetes. 40:1991;1652-1658.
13. Cameron N.E., Cotter M.A., Low P.A. Nerve blood flow in early experimental diabetes in rats: Relation to conduction deficits. Am. J. Physiol. 261:1991;E1-E8.
14. Cameron N.E., Cotter M.A., Dines K.C., Maxfield E.K. Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: Effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Diabetologia. 36:1993;516-522.
15. Cameron N.E., Dines K.C., Cotter M.A. The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats. Diabetologia. 37:1994;1209-1215.
16. Cameron N.E., Cotter M.A., Hohman T.C. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Diabetologia. 39:1996;172-182.
17. Cameron N.E., Cotter M.A., Basso M., Hohman T.C. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia. 40:1997;271-281.
18. Cotter M.A., Cameron N.E. Neuroprotective effects of carvedilol in diabetic rats: Prevention of defective peripheral nerve perfusion and conduction velocity. Naunyn-Schmeidebergs Arch. Pharmacol. 351:1995;630-635.
19. Dines K.C., Cameron N.E., Cotter M.A. Comparison of the effects of evening primrose oil and triglycerides containing γ-linolenic acid on nerve conduction and blood flow in diabetic rats. J. Pharmacol. Exp. Ther. 273:1995;49-55.
20. Dines K.C., Cotter M.A., Cameron N.E. Nerve function in galactosaemic rats: Effects of evening primrose oil and doxazosin. Eur. J. Pharmacol. 281:1995;303-309.
21. Fujii K., Heistad D.D., Faraci F.M. Effects of diabetes mellitus on flow mediated and endothelium-dependent dilation of the rat basilar artery. Stroke. 23:1992;1494-1498.
22. G-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5′-N-ethylcarboxamidoadenosine or salbutamol in conscious rats. Br. J. Pharmacol. 103:1991;1725-1732.
23. Hudlicka O. Regulation of muscle blood flow. Clin. Physiol. 5:1985;201-209.
24. Kamata K., Miyata N., Kasuya Y. Involvement of endothelial cells in relaxation and contraction responses of aorta to isoproterenol in naive and streptozotocin-induced diabetic rats. J. Pharmacol. Exp. Ther. 249:1989;890-894.
25. Keegan A., Walbank H., Cotter M.A., Cameron N.E. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia. 38:1995;1475-1478.
26. Kihara M., Low P.A. Regulation of rat nerve blood flow: Role of epineurial α-receptors. J. Physiol. 422:1990;145-152.
27. Kihara M., Low P.A. Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp. Neurol. 132:1995;180-185.
28. Kihara M., Schmelzer J.D., Poduslo J.F., Curran F.F., Nickander K.K., Low P.A. Aminoguanidine effect on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc. Natl. Acad. Sci. USA. 88:1991;6107-6111.
29. Lass P., Knudsen G.M., Pedersen E.V., Barry D.I. Impaired β-adrenergic mediated cerebral blood flow response in streptozotocin diabetic rats. Pharmacol. Toxicol. 65:1989;318-320.
30. Low P.A., Lagerlund T.D., McManis P.G. Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy. Int. Rev. Neurobiol. 31:1989;355-438.
31. Maxfield E.K., Cameron N.E., Cotter M.A., Dines K.C. Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats. Diabetologia. 36:1993;1230-1237.
32. 1 receptor antagonist. Am. J. Physiol. 269:1995;E530-E537.
33. Maxfield E.K., Cameron N.E., Cotter M.A. Effect of diabetes on reactivity of sciatic vasa nervorum in rats. J. Diabet. Complications. 11:1997;47-55.
34. Ram Z., Sadeh M., Walden R., Adar R. Vascular insufficiency quantitatively aggravates diabetic neuropathy. Arch. Neurol. 48:1991;1239-1242.
35. Randall M.D., McCulloch A.I. The involvement of ATP-sensitive potassium channels in β-adrenoceptor-mediated vasorelaxation in the rat isolated mesenteric arterial bed. Br. J. Pharmacol. 115:1995;607-612.
36. Rebich S., Devine J.O., Armstead W.M. Role of nitric oxide and cAMP in beta-adrenoceptor-induced pial artery vasodilation. Am. J. Physiol. 268:1995;H1071-H1076.
37. Reja A., Tesfaye S., Harris N.D., Ward J.D. Is ACE inhibition with lisinopril helpful in diabetic neuropathy? Diabetic Med. 12:1995;307-309.
38. Rösen P., Ballhausen T., Bloch W., Addicks K. Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: Influence of tocopherol as antioxidant. Diabetologia. 38:1995;1157-1168.
39. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J. Clin. Invest. 94:1994;853-859.
40. Tesfaye S., Malik R., Ward J.D. Vascular factors in diabetic neuropathy. Diabetologia. 37:1994;847-854.
41. Tuck R.R., Schmelzer J.D., Low P.A. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain. 107:1984;935-950.
42. Wang Y.X., Poon K.S., Randall D.J., Pang C.C. Endothelium-derived nitric oxide partially mediates salbutamol-induced vasodilatations. Eur. J. Pharmacol. 250:1993;335-340.
43. Ward K.K., Low P.A., Schmelzer J.D., Zochodne D.W. Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain. 112:1989;197-208.
44. Willette R.N., Sauermelch C.F., Ruffolo R.R. Jr. Local cutaneous hemodynamic effects of carvedilol and labetol in the anesthetized rat. Eur. J. Pharmacol. 176:1990;237-240.
45. Yagihashi S. Pathology and pathogenetic mechanisms of diabetic neuropathy. Diabetes Metab. Rev. 11:1995;193-225.